[Biological preparations and clinical management of collagen diseases--for a breakthrough in therapy].
Tanaka
Yoshiya
Y
D000906:Antibodies / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003095:Collagen Diseases / Q000628:therapy*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000906:Antibodies; D018951:Antigens, CD20; D014409:Tumor Necrosis Factor-alpha